Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Randomized, Modified Double-blind, Active-controlled Study to Assess the Safety of vYF, Yellow Fever Vaccine, in Adults Aged 18 Years up to 60 Years

NCT07002060 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT07002060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07002060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Randomized, Modified Double-blind, Active-controlled Study to Assess the Safety of vYF, Yellow Fever Vaccine, in Adults Aged 18 Years up to 60 Years
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
May 22, 2025
Completion date
January 20, 2026
Enrollment
640 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

yellow fever immunization